A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy ...

One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...

UAE's Burjeel Holdings has joined forces with US-based non-profit Caring Cross to locally manufacture CAR-T (Chimeric Antigen ...

At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ...

Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...

Tolerogenic dendritic cells in the intestines are shown to reduce the immune responses caused by exposure to food proteins.

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...